Dietary Supplement

Omegaplex

64 adverse event reports submitted to the FDA · 2011–2019 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 64 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Vomiting
13
Diarrhoea
11
Nausea
11
Abdominal pain
10
Blood pressure increased
9
Headache
9
Dyspnoea
8
Dehydration
7
Convulsion
7
Dizziness
7

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Other Serious or Important Medical Event 47
Visited Emergency Room 37
Visited a Health Care Provider 23
Hospitalization 18

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
1
18–34
21
35–49
22
50–64
14
65–79
3
80+
1
Unknown
2

62 reports had age data; 2 unknown.

Gender

Female
56
Male
7
Unknown/Not Reported
1

Reports by Year

Annual report counts from 2011–2019. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'11
'12
'13
'14
'15
'16
'17
'18
'19

Hover bars for exact counts.

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data